Innovative Chewing Gum Aims to Combat Cancer-Related Microbes
Researchers at the University of Pennsylvania have developed a chewing gum that may help reduce cancer-associated oral microbes, particularly in patients with head and neck squamous cell carcinoma (HNSCC). The gum, made with proteins from lablab beans, has shown promise in reducing levels of harmful microbes like HPV, Porphyromonas gingivalis, and Fusobacterium nucleatum. The gum's mechanism involves binding viruses and bacteria, potentially offering a complementary treatment to existing therapies. Trials for this antiviral gum are set to begin in the U.S., following evaluations in London. 
